% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Dzel:145135,
author = {Düzel, Emrah and Acosta-Cabronero, Julio and Berron, David
and Biessels, Geert Jan and Björkman-Burtscher, Isabella
and Bottlaender, Michel and Bowtell, Richard and Buchem,
Mark V and Cardenas-Blanco, Arturo and Boumezbeur, Fawzi and
Chan, Dennis and Clare, Stuart and Costagli, Mauro and de
Rochefort, Ludovic and Fillmer, Ariane and Gowland, Penny
and Hansson, Oskar and Hendrikse, Jeroen and Kraff, Oliver
and Ladd, Mark E and Ronen, Itamar and Petersen, Esben and
Rowe, James B and Siebner, Hartwig and Stöcker, Tony and
Straub, Sina and Tosetti, Michela and Uludag, Kamil and
Vignaud, Alexandre and Zwanenburg, Jaco and Speck, Oliver},
title = {{E}uropean {U}ltrahigh-{F}ield {I}maging {N}etwork for
{N}eurodegenerative {D}iseases ({EUFIND}).},
journal = {Alzheimer's $\&$ dementia / Diagnosis, assessment $\&$
disease monitoring},
volume = {11},
number = {1},
issn = {2352-8729},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DZNE-2020-00494},
pages = {538-549},
year = {2019},
abstract = {The goal of European Ultrahigh-Field Imaging Network in
Neurodegenerative Diseases (EUFIND) is to identify
opportunities and challenges of 7 Tesla (7T) MRI for
clinical and research applications in neurodegeneration.
EUFIND comprises 22 European and one US site, including over
50 MRI and dementia experts as well as
neuroscientists.EUFIND combined consensus workshops and data
sharing for multisite analysis, focusing on 7 core topics:
clinical applications/clinical research, highest resolution
anatomy, functional imaging, vascular systems/vascular
pathology, iron mapping and neuropathology detection,
spectroscopy, and quality assurance. Across these topics,
EUFIND considered standard operating procedures, safety, and
multivendor harmonization.The clinical and research
opportunities and challenges of 7T MRI in each subtopic are
set out as a roadmap. Specific MRI sequences for each
subtopic were implemented in a pilot study presented in this
report. Results show that a large multisite 7T imaging
network with highly advanced and harmonized imaging
sequences is feasible and may enable future multicentre
ultrahigh-field MRI studies and clinical trials.The EUFIND
network can be a major driver for advancing clinical
neuroimaging research using 7T and for identifying use-cases
for clinical applications in neurodegeneration.},
cin = {AG Düzel / AG Nestor / AG Stöcker},
ddc = {610},
cid = {I:(DE-2719)5000006 / I:(DE-2719)1310001 /
I:(DE-2719)1013026},
pnm = {344 - Clinical and Health Care Research (POF3-344) / 345 -
Population Studies and Genetics (POF3-345)},
pid = {G:(DE-HGF)POF3-344 / G:(DE-HGF)POF3-345},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31388558},
pmc = {pmc:PMC6675944},
doi = {10.1016/j.dadm.2019.04.010},
url = {https://pub.dzne.de/record/145135},
}